		<rss version="2.0">
		<channel>
		<title>Tequin News RSS Feed - Lawyer Seek Litigation</title>
		<link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Tequin-P112/News/</link>
		<description>What is Tequin?
Bristol-Myers Squibb Company markets Tequin, which has the generic name of gatifloxacin. Tequin is an antibiotic that is prescribed to patients suffering from sinus, lung, or urinary tract infections. Tequin is a member of the class of drugs known as fluoroquinolone antibiotics, which are designed to treat bacterial infections. Other members of the fluoroquinolone antibiotic class of medications include Levaquin, Cipro, and Avelox. Tequin was approved by the FDA in ... </description>
		<language>en-us</language>
		
					<item>
			<title>Accident Raises Safety Concerns About Chinese Tires</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Tequin-P112/News/</link><description>Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature.</description>			
			</item>			
					<item>
			<title>Accident Raises Safety Concerns About Chinese Tires</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Tequin-P112/News/</link><description>Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature</description>			
			</item>			
					<item>
			<title>Problem-plagued antibiotic Tequin being pulled from U.S., Canadian markets</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Tequin-P112/News/</link><description>WASHINGTON (CP) - An antibiotic plagued by serious blood-sugar complications is being pulled by its manufacturer from the U.S. and Canadian markets.</description>			
			</item>			
					<item>
			<title>Antibiotic linked to blood-sugar problems</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Tequin-P112/News/</link><description>An antibiotic plagued by serious blood-sugar complications is coming off the market. Bristol-Myers Squibb confirmed that it plans to stop making and selling Tequin.</description>			
			</item>			
					<item>
			<title>US group seeks ban on discontinued Bristol drug</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Tequin-P112/News/</link><description> U.S. regulators should ban a Bristol-Myers Squibb Co. antibiotic because even though the company no longer makes the drug, which carries certain health risks, there are still supplies available, a co...</description>			
			</item>			
					<item>
			<title>Tequin Antibiotic: Life-Threatening for Elderly?</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Tequin-P112/News/</link><description>The new warning strengthens the existing warning about low blood sugar and high blood sugar, adds a contraindication for use of the drug with diabetics, and includes information about other risk facto...</description>			
			</item>			
					<item>
			<title>Study: Tequin Tied to Blood-Sugar Problems</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Tequin-P112/News/</link><description> Serious blood-sugar complications among people taking the antibiotic Tequin are more common than had been believed, a new study in older people suggests.</description>			
			</item>			
					<item>
			<title>Bristol-Myers&#39;s Tequin Linked to Blood-Sugar Swings (Update1)</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Tequin-P112/News/</link><description>March 1 (Bloomberg) -- Bristol-Myers Squibb Co.&#39;s Tequin antibiotic can cause potentially fatal swings in blood sugar for a broad group of patients, according to a study that researchers say may lead ...</description>			
			</item>			
				
		</channel>
		</rss> 
		